Dolomite Bio specializes in microfluidic droplet applications, offering a range of microfluidic systems and individual modules, as well as control software and reagents, for cell biology applications. Its core droplet technology is fully scalable, enabling microdroplet encapsulation of individual cells and molecules – from a few cells to millions or more – in just a few minutes. It is ideal for a wide variety of high throughput, single cell research applications, including:
- Single cell RNA-Seq
- Direct isolation of functional antibody coding sequence libraries
- Profiling natively-paired T-cell receptors
- Directed evolution by FACS sorting
- Functional antibody screening in droplets
- Cell encapsulation in hydrogels
Mike Hawes, CEO of Dolomite Bio, said: “We are delighted to announce the launch of Dolomite Bio, which will focus on developing novel products for high throughput single cell research. This new brand takes advantage of Dolomite Microfluidics’ underlying technology and the Blacktrace group’s understanding of the market to serve customers in this rapidly growing field.”
For more information, visit www.dolomite-bio.com
__________________________________________________